ArticleOPEN ACCESS

Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma

Blood Cancer Journal
DOI: 10.1038/BCJ.2016.21
36Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Ratner, L., Rauch, D., Abel, H., Caruso, B., Noy, A., Barta, S. K., … Jacobson, S. (2016, March 1). Dose-adjusted EPOCH chemotherapy with bortezomib and raltegravir for human T-cell leukemia virus-associated adult T-cell leukemia lymphoma. Blood Cancer Journal. Springer Nature. https://doi.org/10.1038/BCJ.2016.21

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free